Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients.

MLA

Kumar, Lakshin, et al. “Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients.” Clinical Infectious Diseases, vol. 78, no. 3, Mar. 2024, pp. 719–22. EBSCOhost, https://doi.org/10.1093/cid/ciad643.

APA

Kumar, L., Dasgupta, S., Murray-Krezan, C., Singh, N., Rakita, R. M., Fisher, C. E., & Limaye, A. P. (2024). Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients. Clinical Infectious Diseases, 78(3), 719–722. https://doi.org/10.1093/cid/ciad643

Chicago

Kumar, Lakshin, Sayan Dasgupta, Cristina Murray-Krezan, Nina Singh, Robert M Rakita, Cynthia E Fisher, and Ajit P Limaye. 2024. “Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients.” Clinical Infectious Diseases 78 (3): 719–22. doi:10.1093/cid/ciad643.